Scilex Holding (SCLX) Capital Expenditures (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Capital Expenditures of $200000.0 for Q1 2026, up 19900.0% on a QoQ basis from $1000.0 in Q4 2023.

Scilex Holding (SCLX) Capital Expenditures (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Capital Expenditures for 3 consecutive years, with $200000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Capital Expenditures changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (up 19900.0% YoY), while the FY2025 annual figure was $133000.0, changed N/A from the prior year.
  • Capital Expenditures came in at $200000.0 for Q1 2026 at Scilex Holding, up from $1000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $200000.0 in Q1 2026, with the low at $1000.0 in Q4 2023.
  • Average Capital Expenditures over 3 years is $57250.0, with a median of $14000.0 recorded in 2022.
  • The largest YoY upside for Capital Expenditures was 200.0% in 2023 against a maximum downside of 200.0% in 2023.
  • Year by year, Capital Expenditures stood at $7000.0 in 2022, then tumbled by 85.71% to $1000.0 in 2023, then jumped by 19900.0% to $200000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $200000.0, $1000.0, and $21000.0 for Q1 2026, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 2.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 265.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -547.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 991.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 712.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 117.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 436.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -346.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 200,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Mar 31, 2026 200,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 21,000.00
Sep 30, 2023 21,000.00
Sep 30, 2022 7,000.00
Sep 30, 2022 7,000.00